Plerixafor, cyclophosphamide and G-CSF and Blood cell mobilization in a patient with acute promyelocytic leukemia

J Clin Apher. 2017 Dec;32(6):592-593. doi: 10.1002/jca.21516. Epub 2016 Oct 27.

Authors

Gregorio Jaimovich¹, Martin Castro¹, Belen Rosales Ostriz¹, Maria Fernandez¹, Dolores Silveyra¹, Reinaldo Campestri¹

Affiliation

¹ Bone Marrow Transplant Department, Sanatorio Anchorena, Buenos Aires, Argentina.

PMID: 27787909
DOI: 10.1002/jca.21516

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Benzylamines
Blood Cells / drug effects
Cyclams
Cyclophosphamide / therapeutic use
Granulocyte Colony-Stimulating Factor / therapeutic use
Hematopoietic Stem Cell Mobilization / methods*
Heterocyclic Compounds / therapeutic use
Humans
Leukemia, Promyelocytic, Acute / drug therapy
Leukemia, Promyelocytic, Acute / therapy*
Male
Middle Aged

Substances

Benzylamines
Cyclams
Heterocyclic Compounds
Granulocyte Colony-Stimulating Factor
Cyclophosphamide
plerixafor